Biogen Inc. buy Piper Sandler
Start price
14.02.24
/
50%
€207.20
Target price
14.02.25
€302.90
Performance (%)
-35.45%
End price
15.02.25
€133.75
Summary
This prediction ended on 15.02.25 with a price of €133.75. The BUY prediction by Piper_Sandler for Biogen Inc. performed very badly with a performance of -35.45%. Piper_Sandler has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 2.372% | 2.372% | 54.860% |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % |
Comments by Piper_Sandler for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Piper Sandler from $350.00 to $325.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten